Uronostics Oy is a Finnish OY based in Espoo, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2020.
Solidity ratio Equity ÷ Total assets × 100 2021 2024
Liquidity ratio Current assets ÷ Short-term debt 2021 2024
Return on assets (ROA) Net profit ÷ Total assets × 100 2021 2024
EBITDA — year on year EUR millions 0M 0M 0M -1M -1M 2021: 0M 0M 2021 2022: 0M 0M 2022 2024: 0M 0M 2024
Key figures Annual report 2024 Revenue — — EBITDA −2 t. € — Net profit −2 t. € — Total assets 0,6 t. € +3% Equity −2,4 t. € -488% Employees — —
Founded
26 March 2020 · 6 years
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Yhtiön päätoimiala on lääketieteellinen tutkimus ja kehittäminen. Yhtiön sivutoimiala on kaikki laillinen liiketoiminta.
(no translation available)
Address
Tontunmäentie 35B-3577, 02200
Espoo Email
tuomas.mirtti@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development The figures on this page draw on 3 annual filings covering 2021 to 2024. The bottom line showed a net loss of 2,0 t. €.
At the end of 2024, current assets covered short-term debt 0.2 times.
Frequently asked questions What is the Y-tunnus number of Uronostics Oy? Uronostics Oy is registered with PRH / YTJ under Y-tunnus 3128380-8.
Where is Uronostics Oy headquartered? Uronostics Oy's registered address is Tontunmäentie 35-B77.
